Mcl-1 small-molecule inhibitors encapsulated into nanoparticles exhibit increased killing efficacy towards HCMV-infected monocytes.
Mcl-1 small-molecule inhibitors encapsulated into nanoparticles exhibit increased killing efficacy towards HCMV-infected monocytes.
复制标题
DOI:
10.1016/j.antiviral.2016.11.027
复制
发表时间:
2017-03
影响因子:
7.6
通讯作者:
Chan GC
中科院分区:
文献类型:
--
作者:
Burrer CM;Auburn H;Wang X;Luo J;Abulwerdi FA;Nikolovska-Coleska Z;Chan GC
Human cytomegalovirus (HCMV) spreads and establishes a persistent infection within a host by stimulating the survival of carrier myeloid cells via the upregulation of Mcl-1, an antiapoptotic member of the Bcl-2 family of proteins. However, the lack of potent Mcl-1-specific inhibitors and a targetable delivery system has limited to ability to exploit Mcl-1 as a therapeutic strategy to eliminate HCMV-infected monocytes. In this study, we found a lead compound from a novel class of Mcl-1 small-molecule inhibitors rapidly induced death of HCMV-infected monocytes. Moreover, encapsulation of Mcl-1 antagonists into myeloid cell-targeting nanoparticles was able to selectively increase the delivery of inhibitors into HCMV-activated monocytes, thereby amplifying their potency. Our study demonstrates the potential use of nanotechnology to target Mcl-1 small-molecule inhibitors to HCMV-infected monocytes.
登录
查看更多内容
影响因子:
14
作者:
Cai, Liqiong;Xu, Gaofei;Shi, Changying;Guo, Dandan;Wang, Xu;Luo, Juntao
通讯作者:
Luo, Juntao
影响因子:
--
作者:
Cohen NA;Stewart ML;Gavathiotis E;Tepper JL;Bruekner SR;Koss B;Opferman JT;Walensky LD
通讯作者:
Walensky LD
影响因子:
3.6
作者:
Noyola, DE;Demmler, GJ;Yow, MD
通讯作者:
Yow, MD
DOI:
10.4049/jimmunol.0903025
发表时间:
2010-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Chan G;Nogalski MT;Bentz GL;Smith MS;Parmater A;Yurochko AD
通讯作者:
Yurochko AD
影响因子:
12.4
作者:
Patel SK;Janjic JM
通讯作者:
Janjic JM